Olema Pharmaceuticals Inc... (OLMA)
NASDAQ: OLMA
· Real-Time Price · USD
5.46
0.20 (3.80%)
At close: Aug 15, 2025, 12:51 PM
3.80% (1D)
| Bid | 5.45 |
| Market Cap | 374.74M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -128.89M |
| EPS (ttm) | -1.97 |
| PE Ratio (ttm) | -2.77 |
| Forward PE | -2.13 |
| Analyst | Buy |
| Ask | 5.47 |
| Volume | 239,723 |
| Avg. Volume (20D) | 693,216 |
| Open | 5.30 |
| Previous Close | 5.26 |
| Day's Range | 5.30 - 5.54 |
| 52-Week Range | 2.86 - 13.93 |
| Beta | 1.93 |
About OLMA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OLMA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OLMA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
+16.19%
Olema Pharmaceuticals shares are trading higher. T...
Unlock content with
Pro Subscription
8 months ago
+0.89%
Olema Pharmaceutical shares are trading higher after the company announced a new clinical trial collaboration and supply agreement with Novartis for frontline metastatic breast cancer. Also, the company entered into a private placement of common stock worth $250 million.
